Vertex builds up pipeline of type 1 diabetes cell therapies with $320M buyout - MedCity News
Vertex Provides an Update on the VX-880 Clinical Trial - JDRF
A Cure for Type 1 Diabetes? For One Man, It Seems to Have Worked. - The New York Times
Stem Cell Therapy for Type 1 Diabetes: Patient Achieved Insulin Independence on Day 270
A new therapy for treating Type 1 diabetes | Harvard Stem Cell Institute (HSCI)
Vertex Type 1 Diabetes Research Stirs Hope for Stem Cell-Based 'Cure'
Clinical Trial for Novel Investigational Treatment of Type 1 Diabetes Open for Enrollment in Miami | Regenerative Medicine Foundation
Clinical Trial Tests Stem Cell Therapy to Cure People with Type 1 Diabetes
Engineering islets from stem cells for advanced therapies of diabetes | Nature Reviews Drug Discovery
Vertex spends nearly $1bn on Semma's unproven diabetes cell tech | Evaluate
Stem Cells and the Search For a Type 1 Diabetes Cure
Vertex to acquire ViaCyte, targeting type 1 diabetes
How stem cells could fix type 1 diabetes
Why stem cells may be the answer to curing Type 1 diabetes
Vertex: Trial of New Type 1 Diabetes Cell Therapy Put on Hold - DSM
Frontiers | Engineering Islets From Stem Cells: The Optimal Solution for the Treatment of Diabetes?
Frontiers | Stem Cell-Based Clinical Trials for Diabetes Mellitus
Vertex Expanding into Diabetes Cell Therapy with Plans to Acquire Semma
JDRF Report: Vertex Has a New Horizon: Curing Type 1 Diabetes
Vertex's Stem Cell-Based Type 1 Diabetes Therapy To Enter Human Trial Stage | The Healthcare Technology Report.
ViaCyte's Future 'Functional Diabetes Cure' for Diabetes
Vertex buys developer of preclinical cell therapy for Type 1 diabetes for $950M - MedCity News
Vertex – type 1 diabetes vs stem cell therapy - The Boar
